Trials / Recruiting
RecruitingNCT06598215
Hybrid Duckett vs Modified Duckett Urethroplasty for Proximal Hypospadias
Hybrid Duckett Urethroplasty Versus Modified Single Stage Duckett Uteothroplasty for Management of Proximal Hypospadias: a Randomized Clinical Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 43 (estimated)
- Sponsor
- Tanta University · Academic / Other
- Sex
- Male
- Age
- 6 Months – 18 Years
- Healthy volunteers
- Not accepted
Summary
proximal hypospadias presents a serious anomaly for both infants and their care givers. a variety of techniques were described through decades. None of them is completely curable. hundred of modifications were adopted to the original techniques. during the current study, we will do hybrid Duckett urethroplasty which is a staged procedure and compare it to modified Duckett urethroplasty which is a single stage procedure.
Detailed description
two groups of infants diagnosed with proximal hypospadias will be allocated in two groups. group A will include cases of who will be operated upon using hybrid Duckett urethroplasty. group B will include patients who will be operated upon using modified duckett urethroplasty. recruitment in either group will be done using sealed envelop method. in group A patient will have a double face Duckett tube which will be transferred to the ventral of the penis. the tube will be secured in place however, no proximal anastomosis with the meatus. the anastomosis will be scheduled six months later. In group B patients a double face Duckett tube will be transferred to the ventral aspect of the penis with completion of the anastomosis with the proximal meatus at the same session. the primary out come will be completion of the procedure and restoration of the urethral continuity. secondary out come will the cosmetic appearance
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Duckett urethroplasty | hybrid duckett urethroplasty vs modified duckett urethroplasty |
Timeline
- Start date
- 2024-10-01
- Primary completion
- 2026-08-01
- Completion
- 2026-08-01
- First posted
- 2024-09-19
- Last updated
- 2024-09-19
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06598215. Inclusion in this directory is not an endorsement.